SIRPA and neoplasm: Although these studies highlight the prominent role of the CD47-SIRPα pathway in inhibiting tumor cell phagocytosis and promoting tumor immune evasion, the specific role and immunoregulatory mechanisms of the CD47-SIRPα pathway in ESCC remain poorly understood.